Polson [POLSON] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

Polson Ltd.

BSE
Loading...

Neogen Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Polson Ltd. wins in 15 metrics, Neogen Chemicals Ltd. wins in 4 metrics, with 0 ties. Polson Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Polson Ltd. Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 27.93 222.22 Polson Ltd.
Price-to-Book Ratio 1.10 5.46 Polson Ltd.
Debt-to-Equity Ratio 31.93 141.47 Polson Ltd.
PEG Ratio -9.88 -3.52 Neogen Chemicals Ltd.
EV/EBITDA 11.40 42.55 Polson Ltd.
Profit Margin (TTM) 5.50% 2.41% Polson Ltd.
Operating Margin (TTM) 11.82% 11.39% Polson Ltd.
EBITDA Margin (TTM) 11.82% 11.39% Polson Ltd.
Return on Equity 4.13% 4.41% Neogen Chemicals Ltd.
Return on Assets (TTM) 2.77% 1.99% Polson Ltd.
Free Cash Flow (TTM) $-39.69M $-1.22B Polson Ltd.
Dividend Yield N/A 0.19% N/A
1-Year Return -12.17% 10.59% Neogen Chemicals Ltd.
Price-to-Sales Ratio (TTM) 1.54 5.56 Polson Ltd.
Enterprise Value $1.82B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 1.98 6.55 Polson Ltd.
Gross Profit Margin (TTM) 52.19% 47.11% Polson Ltd.
Revenue per Share (TTM) $7,672 $310 Polson Ltd.
Earnings per Share (Diluted) $422.09 $7.47 Polson Ltd.
Beta (Stock Volatility) 0.21 0.22 Polson Ltd.

Polson Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

POLSON
NEOGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Polson Ltd.-4.26%0.00%0.88%-1.29%-2.54%0.23%
Neogen Chemicals Ltd.1.29%5.78%11.27%35.92%70.61%59.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Polson Ltd.-12.17%0.67%-1.53%55.19%6,428.53%6,428.53%
Neogen Chemicals Ltd.10.59%19.04%106.75%609.06%609.06%609.06%

Performance & Financial Health Analysis: Polson Ltd. vs Neogen Chemicals Ltd.

MetricPOLSONNEOGEN
Market Information
Market Cap i₹1.37B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i22170,744
90 Day Avg. Volume i20127,390
Last Close₹11,010.00₹1,901.20
52 Week Range₹9,530.00 - ₹14,370.00₹966.70 - ₹1,960.30
% from 52W High-23.38%-3.01%
All-Time High₹26,336.55 (Jan 15, 2018)₹2,420.00 (Dec 09, 2024)
% from All-Time High-58.19%-21.44%
Growth Metrics
Quarterly Revenue Growth-0.02%0.09%
Quarterly Earnings Growth-0.03%-0.63%
Financial Health
Profit Margin (TTM) i0.06%0.02%
Operating Margin (TTM) i0.12%0.11%
Return on Equity (TTM) i0.04%0.04%
Debt to Equity (MRQ) i31.93141.47
Cash & Liquidity
Book Value per Share (MRQ)₹10,735.19₹303.78
Cash per Share (MRQ)₹61.41₹57.58
Operating Cash Flow (TTM) i₹145.06M₹645.50M
Levered Free Cash Flow (TTM) i₹52.31M₹348.30M
Dividends
Last 12-Month Dividend Yield iN/A0.19%
Last 12-Month Dividend iN/A₹3.00

Valuation & Enterprise Metrics Analysis: Polson Ltd. vs Neogen Chemicals Ltd.

MetricPOLSON (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.93222.22
Forward P/E iN/A72.26
PEG Ratio i-9.88-3.52
Price to Sales (TTM) i1.545.56
Price to Book (MRQ) i1.105.46
Market Capitalization
Market Capitalization i₹1.37B₹44.76B
Enterprise Value i₹1.82B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i1.986.55
Enterprise to EBITDA i11.4042.55
Risk & Other Metrics
Beta i0.210.22
Book Value per Share (MRQ) i₹10,735.19₹303.78

Financial Statements Comparison: Polson Ltd. vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPOLSON (2025)NEOGEN (2025)
Revenue/Sales i932.81M7.58B
Cost of Goods Sold i502.95M4.44B
COGS % of Revenue i53.9%58.6%
Gross Profit i429.86M3.13B
Gross Margin i46.1%41.4%
Research & Development i1.01M11.50M
Operating Income (EBIT) i88.24M1.09B
Operating Margin i9.5%14.4%
EBITDA i157.16M1.31B
EBITDA Margin i16.8%17.3%
Pre-Tax Income i71.38M501.60M
Pre-Tax Income % of Revenue i7.7%6.6%
Income Tax i19.07M153.30M
Income Tax % of Revenue i2.0%2.0%
Net Income (Profit) i52.31M348.30M
Profit Margin i5.6%4.6%

Balance Sheet & Liquidity Metrics

MetricPOLSON (2025)NEOGEN (2025)
Cash & Equivalents i11.36M49.60M
Total Current Assets i361.57M10.00B
Total Current Assets % of Revenue i38.8%132.0%
Total Current Liabilities i270.63M7.33B
Total Current Liabilities % of Revenue i29.0%96.8%
Long-Term Debt i258.64M1.94B
Long-Term Debt % of Revenue i27.7%25.6%
Total Shareholders Equity i1.27B7.89B
Retained Earnings i1.17B2.28B
Retained Earnings % of Revenue i125.4%30.1%
Property, Plant & Equipment i0890.30M

Cash Flow Statement Comparison

MetricPOLSON (2025)NEOGEN (2025)
Operating Cash Flow i145.06M645.50M
Operating Cash Flow % of Revenue i15.6%8.5%
Capital Expenditures i-202.93M-3.17B
Free Cash Flow i-39.69M-1.22B
FCF Margin i-4.3%-16.1%
Debt Repayment iN/A-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPOLSONNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i120,00027.38M
Float Shares i30,01913.28M
% Held by Insiders i74.98%53.98%
% Held by Institutions i0.00%23.81%
% Held by Public i25.02%22.21%

Dividend Analysis & Yield Comparison: Polson Ltd. vs Neogen Chemicals Ltd.

MetricPOLSONNEOGEN
Last 12-Month Dividend iN/A₹3.00
Last 12-Month Dividend Yield iN/A0.19%
3-Year Avg Annual Dividend iN/A₹2.00
3-Year Avg Dividend Yield iN/A0.11%
3-Year Total Dividends iN/A₹6.00
Ex-Dividend DateN/ASep 19, 2025